CoChat

The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene

Open access
Gottesman, Michael M., Pastan, Ira H. · 2015 · Journal of the National Cancer Institute
Cited by 148

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The Journal of the National Cancer Institute published our paper entitled “Expression of a Multidrug Resistance Gene in Human Cancers” ( 1 ) 26 years ago. It was the first systematic determination of whether the energy-dependent multidrug efflux pump P-glycoprotein (P-gp), the product of the ABCB1 (MDR1) gene, was expressed in human cancers and has been cited over 1200 times. Four hundred cancers were studied, and the conclusion was that expression was widespread both in intrinsically drug-resistant cancers such as colon, pancreatic, liver, adrenocortical, and kidney cancers, and in some cancers that acquired resistance, such as leukemias, lymphomas, breast cancer, and neuroblastoma. Other cancers at the time of initial presentation, such as lung cancers (except for neuroendocrine tumors), ovarian cancer, esophageal cancer, and mesothelioma expressed little or no P-glycoprotein. The major conclusions of this paper, which have withstood the test of time (see below) were: 1) that P-gp was expressed at levels sufficient to confer drug resistance in many different difficult-to-treat cancers, 2) that its expression appeared during the acquisition of resistance for some cancers, indicating a possible role for P-gp in acquired resistance, 3) that many cancers did not appear to express P-gp mRNA at detectable levels and therefore efforts to inhibit P-gp and reverse resistance in these cancers were unlikely to succeed, and 4) that it remained to be proven whether P-gp expression, though perhaps sufficient for drug resistance in cancers, was the main cause of resistance in any cancer. Considerable effort has been devoted to answer this last question: Are P-gp or other multidrug transporters discovered since (see below) useful targets for drug development with the possible outcome of reversing multidrug resistance in cancer?

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djv222

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 148

Metadata

Authors
Gottesman, M. M., & Pastan, I. H.
Venue
Journal of the National Cancer Institute
Published
2015-08-18
Volume
107
Issue
9
Pages
djv222
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W1887030992
Cited by
148
References
3
FWCI
2.86
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene. https://app.cochat.ai/papers/10.1093/jnci/djv222
The paper
Gottesman, M. M., & Pastan, I. H. (2015). The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djv222

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.